Journal of General Virology article published
Work carried out by TVG and collaborators to isolate and sequence cytomegaloviruses from mastomys rats has been published in the
29 August 2023
Work carried out by TVG and collaborators to isolate and sequence cytomegaloviruses from mastomys rats has been published in the
TVG’s CEO Jeremy Salt met with S&P Global Animal Health at the recent VetHealth Global forum on Canada’s Prince Edward
TVG’s CEO Jeremy Salt was interviewed recently for the online series ‘Future Biotechnologists’. Read the story here.
Dr Jeremy Salt will be attending the VetHealthGlobal meeting in Prince Edward Island next week. A great opportunity to meet
Dr Jeremy Salt, CEO, will be attending BioSeed 2023 on behalf of The Vaccine Group. A great opportunity to talk
TVG CEO, Jeremy Salt, discusses the recent successful completion of the Streptococcus suis and transmissible Lassa fever vaccine projects.
Most emerging infectious diseases affecting humans in the last century originated in animal reservoirs and are defined as zoonotic. Lassa
TVG has completed a successful Anglo-Chinese project backed by the Department of Health and Social Care (DHSC), Innovate UK, and
As TVG prepares for future growth a new position of Laboratory Manager has been created and we are delighted to